6,7-dihydro-pyrazolo[1,2-a]pyrazol-1-on es which control inflammatory cytokines

Details for Australian Patent Application No. 2003218280 (hide)

International Classifications

Event Publications

31 July 2003 Complete Application Filed

Priority application(s): 10/246,214 18.09.02 US

20 May 2004 Application Open to Public Inspection

Published as AU-B-2003218280

15 May 2008 Application Accepted

Published as AU-B-2003218280

26 June 2008 Corrigenda

Applications Accepted - Name Index Under the Name The Procter & Gamble Company, Application No. 2003218280, under INID (54), correct the title of the invention to 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

11 September 2008 Standard Patent Sealed

14 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.